NO930401L - Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav - Google Patents

Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav

Info

Publication number
NO930401L
NO930401L NO93930401A NO930401A NO930401L NO 930401 L NO930401 L NO 930401L NO 93930401 A NO93930401 A NO 93930401A NO 930401 A NO930401 A NO 930401A NO 930401 L NO930401 L NO 930401L
Authority
NO
Norway
Prior art keywords
methods
peptides
hiv infections
blocking hiv
hiv
Prior art date
Application number
NO93930401A
Other languages
English (en)
Other versions
NO930401D0 (no
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Vaccine Dev Kb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Vaccine Dev Kb filed Critical Syntello Vaccine Dev Kb
Publication of NO930401D0 publication Critical patent/NO930401D0/no
Publication of NO930401L publication Critical patent/NO930401L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er funnet at relativt korte peptider som tripep-tidet glycin-prolyl-glycin er i stand til effektivt å inhibere HIV-infeksjon av celler og syncytiadannelse mellom EIV-infiserte og ikke-infiserte celler.Peptidene egner for terapi av pasienter som er infisert med HIV og ved prevensjon av HIV-infeks]on.
NO93930401A 1990-08-22 1993-02-05 Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav NO930401L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22
PCT/SE1991/000544 WO1992003147A1 (en) 1990-08-22 1991-08-20 Peptides that block human immunodeficiency virus infections and methods of use thereof

Publications (2)

Publication Number Publication Date
NO930401D0 NO930401D0 (no) 1993-02-05
NO930401L true NO930401L (no) 1993-02-17

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930401A NO930401L (no) 1990-08-22 1993-02-05 Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav

Country Status (17)

Country Link
EP (1) EP0545991B1 (no)
JP (1) JP3115596B2 (no)
KR (1) KR100220531B1 (no)
AT (1) ATE173934T1 (no)
AU (1) AU667290B2 (no)
BR (1) BR9106772A (no)
CA (1) CA2088788C (no)
DE (1) DE69130571T2 (no)
DK (1) DK0545991T3 (no)
ES (1) ES2128322T3 (no)
FI (1) FI930519A (no)
GR (1) GR3029523T3 (no)
HU (1) HUT63177A (no)
MC (1) MC2306A1 (no)
NO (1) NO930401L (no)
OA (1) OA10051A (no)
WO (1) WO1992003147A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523157A (ja) * 2006-01-13 2009-06-18 オンコレー アーベー 虚血および神経変性の処置のための化合物
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
NO930401D0 (no) 1993-02-05
JP3115596B2 (ja) 2000-12-11
DK0545991T3 (da) 1999-08-16
HU9300456D0 (en) 1993-05-28
GR3029523T3 (en) 1999-06-30
FI930519A (fi) 1993-04-21
HUT63177A (en) 1993-07-28
OA10051A (en) 1996-10-14
AU8433291A (en) 1992-03-17
MC2306A1 (fr) 1993-09-27
CA2088788C (en) 2003-12-16
DE69130571T2 (de) 1999-06-17
JPH06504035A (ja) 1994-05-12
EP0545991A1 (en) 1993-06-16
AU667290B2 (en) 1996-03-21
FI930519A0 (fi) 1993-02-05
KR100220531B1 (ko) 1999-10-01
CA2088788A1 (en) 1992-02-23
WO1992003147A1 (en) 1992-03-05
BR9106772A (pt) 1993-07-20
EP0545991B1 (en) 1998-12-02
DE69130571D1 (de) 1999-01-14
ATE173934T1 (de) 1998-12-15
ES2128322T3 (es) 1999-05-16

Similar Documents

Publication Publication Date Title
TR199903053T2 (xx) Benzimidazol t�revleri.
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DK0541692T3 (da) Herpes simplex virus VP-16-vacciner
ATE476984T1 (de) Behandlung von herpes infektion mit anwendung von immunomodulatore polynukleotide sequenzen
MX9606732A (es) Compuestos terapeuticos.
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
ES2148247T3 (es) Procedimiento de preparacion de liofilizado de cetrorelix.
IL104780A0 (en) Sulfonic acid derivatives in the treatment of viral diseases
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ATE169822T1 (de) Behandlung von herpesvirus infektion
NO930401D0 (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav
ATE201693T1 (de) Hämoregulierende peptide
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ITMI913493A1 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
RU93005034A (ru) Пептиды, блокирующие инфекцию вируса иммунодефицита человека, способы их применения
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
IT1246296B (it) Procedimento di estrzione e purificazione del gamma interferone umano ricombinante
ES8605576A1 (es) Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b